|
06 Mar 2007 |
AlphaRx Announces Completion of Phase II Clinical Trial for Indaflex
|
|
06 Mar 2007 |
Actelion: Positive Study With Bosentan (Tracleer) in CTEPH
|
|
06 Mar 2007 |
Biocryst And Shionogi Establish Collaboration In Japan
|
|
06 Mar 2007 |
YM BioSciences completes enrolment of AeroLEF(TM) Phase IIB pain trial
|
|
03 Mar 2007 |
Sebivo(R) approved in China for treatment of chronic hepatitis B, the nation's second leading cause of death
|
|
03 Mar 2007 |
FDA Approves Astellas' Vaprisol for the Treatment of Hypervolemic Hyponatremia
|
|
03 Mar 2007 |
Lipitor Significantly Reduced the Risk of Serious Cardiovascular Events Compared With Simvastatin in an 80,000-Patient Analysis of a Real-World Managed Care Database
|
|
02 Mar 2007 |
Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients
|
|
02 Mar 2007 |
Sunesis Pharmaceuticals Files Investigational New Drug Application for Novel Aurora Kinase Inhibitor, SNS-314
|
|
02 Mar 2007 |
EMEA Accepts for Review Thalidomide Pharmion(R) Marketing Authorization Application for Untreated Multiple Myeloma
|
|
02 Mar 2007 |
Insert Therapeutics Signs New Partnership With R&D Biopharmaceuticals
|
|
02 Mar 2007 |
KeyNeurotek AG and Grünenthal GmbH sign exclusive licensing agreement for drug development and marketing
|
|
02 Mar 2007 |
Point Therapeutics Provides Clinical Update
|
|
02 Mar 2007 |
CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne
|
|
02 Mar 2007 |
New Data on Investigational Agent TMC278 in Anitretroviral-Naive HIV Patients
|
|
02 Mar 2007 |
Results from Two Phase III Studies on ISENTRESS(TM) (raltegravir, MK-0518), Merck's Oral Investigational Integrase Inhibitor Presented at the Annual Conference on Retroviruses and Opportunistic Infections (CROI)
|
|
02 Mar 2007 |
Preclinical Data From Two Novel Idenix Compounds for the Treatment of HIV Presented at Conference on Retroviruses and Opportunistic Infections (CROI)
|
|
02 Mar 2007 |
Gilead Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137
|
|
01 Mar 2007 |
Evotec and Interprotein Sign Collaboration Agreement to Develop Interleukin 6 Inhibitors to Treat Inflammatory Diseases
|
|
01 Mar 2007 |
Pharmasset Initiates Multiple Ascending Dose Study of R7128 in Patients Chronically Infected with HCV Genotype 1
|
|
01 Mar 2007 |
Accentia Biopharmaceuticals Acquires Worldwide Exclusive License to Revimmune for All Autoimmune Diseases
|
|
01 Mar 2007 |
AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA
|
|
01 Mar 2007 |
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
|
|
01 Mar 2007 |
Phase III Sativex(R) Data Published in Leading Neurology Journal
|
|
01 Mar 2007 |
Marinus Pharmaceuticals Initiates Phase IIb Study of Ganaxolone for Infantile Spasms
|
